Federated Hermes’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-556
| Closed | -$37.5K | – | 2132 |
|
|
2023
Q2 | $37.5K | Sell |
556
-1,990
| -78% | -$823K | ﹤0.01% | 1714 |
|
|
2023
Q1 | $1.19M | Buy |
2,546
+1,707
| +203% | +$903K | ﹤0.01% | 1118 |
|
|
2022
Q4 | $336K | Sell |
839
-3,795
| -82% | -$1.45M | ﹤0.01% | 1452 |
|
|
2022
Q3 | $1.51M | Sell |
4,634
-34,470
| -88% | -$11.1M | ﹤0.01% | 991 |
|
|
2022
Q2 | $10.3M | Sell |
39,104
-56,731
| -59% | -$14.5M | 0.03% | 539 |
|
|
2022
Q1 | $28.8M | Buy |
95,835
+43,776
| +84% | +$15.3M | 0.07% | 359 |
|
|
2021
Q4 | $18.4M | Buy |
52,059
+31,313
| +151% | +$9.75M | 0.03% | 511 |
|
|
2021
Q3 | $5.3M | Buy |
+20,746
| New | +$7.35M | 0.01% | 811 |
|
|
2021
Q2 | – | Sell |
-2,660
| Closed | -$2.31M | – | 2253 |
|
|
2021
Q1 | $2.31M | Sell |
2,660
-427
| -14% | -$455K | ﹤0.01% | 1057 |
|
|
2020
Q4 | $2.86M | Buy |
3,087
+312
| +11% | +$328K | 0.01% | 953 |
|
|
2020
Q3 | $2.85M | Buy |
+2,775
| New | +$2.99M | 0.01% | 879 |
|
|
2020
Q2 | – | Hold |
0
| – | -$1K | – | 2279 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2105 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$1K | – | 2232 |
|
|
2019
Q2 | $1K | Sell |
1
-1,865
| -100% | -$2.04M | ﹤0.01% | 2108 |
|
|
2019
Q1 | $2.54M | Buy |
+1,866
| New | +$2.53M | 0.01% | 968 |
|
|
2018
Q4 | – | Sell |
-170
| Closed | -$259K | – | 2227 |
|
|
2018
Q3 | $259K | Sell |
170
-863
| -84% | -$1.33M | ﹤0.01% | 1573 |
|
|
2018
Q2 | $1.62M | Buy |
1,033
+1,002
| +3,232% | +$1.31M | ﹤0.01% | 1112 |
|
|
2018
Q1 | $36K | Sell |
31
-29
| -48% | -$38.2K | ﹤0.01% | 1682 |
|
|
2017
Q4 | $71K | Sell |
60
-1,037
| -95% | -$1.3M | ﹤0.01% | 1628 |
|
|
2017
Q3 | $1.48M | Buy |
1,097
+1,022
| +1,363% | +$1.08M | ﹤0.01% | 1061 |
|
|
2017
Q2 | $61K | Sell |
75
-5
| -6% | -$3.48K | ﹤0.01% | 1634 |
|
|
2017
Q1 | $49K | Sell |
80
-17
| -18% | -$10.4K | ﹤0.01% | 1637 |
|
|
2016
Q4 | $52K | Sell |
97
-32
| -25% | -$16K | ﹤0.01% | 1661 |
|
|
2016
Q3 | $67K | Buy |
129
+42
| +48% | +$19.8K | ﹤0.01% | 1600 |
|
|
2016
Q2 | $36K | Sell |
87
-8
| -8% | -$3.66K | ﹤0.01% | 1700 |
|
|
2016
Q1 | $50K | Sell |
95
-1
| -1% | -$498 | ﹤0.01% | 1664 |
|
|
2015
Q4 | $73K | Buy |
+96
| New | +$63.7K | ﹤0.01% | 1607 |
|
Other funds holding KYNB
AC
Federated Hermes's KYNB Position: Q3 2023 in Review
Federated Hermes sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 556 shares — an estimated $37.5K sold.
Federated Hermes first reported a position in KYNB in Q4 2015 and held it in 25 quarters. The position peaked at $28.8M in Q1 2022. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.
- Federated Hermes reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
- Federated Hermes sold 556 Kyntra Bio shares in Q3 2023, an estimated $37.5K.
- Federated Hermes first reported a position in Kyntra Bio in Q4 2015 and held it in 25 quarters.
- Federated Hermes's Kyntra Bio position peaked at $28.8M in Q1 2022.
- 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.
Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.